Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
326
-
Total 13F shares, excl. options
-
130M
-
Shares change
-
+3.9M
-
Total reported value, excl. options
-
$4.89B
-
Value change
-
+$140M
-
Put/Call ratio
-
0.65
-
Number of buys
-
152
-
Number of sells
-
-148
-
Price
-
$37.77
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2022
397 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2022.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 326 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130M shares
of 159M outstanding shares and own 81.71% of the company stock.
Largest 10 shareholders include FMR LLC (21.3M shares), VANGUARD GROUP INC (13.5M shares), T. Rowe Price Investment Management, Inc. (11.7M shares), Bellevue Group AG (9.74M shares), BlackRock Inc. (9.08M shares), Clearbridge Investments, LLC (5.43M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.29M shares), STATE STREET CORP (4.22M shares), Tweedy, Browne Co LLC (3.54M shares), and ARK Investment Management LLC (2.67M shares).
This table shows the top 326 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.